前沿论文｜CELL INTELLIGENCE

Adoptive cell therapies in solid tumors: current clinical landscape, challenges, and future directions.

PubMed 2026/05/14 发表Front ImmunolQ1 · IF 7（JCR 2025）

69.4分

★★★☆☆

站内排序·非疗效

Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies.

PubMed 2026/04/10 发表BioimpactsQ3 · IF 2.5（JCR 2025）

50.8分

★★★☆☆

站内排序·非疗效

CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study.

PubMed 2022/07/16 发表Int ImmunopharmacolQ1 · IF 5.6（JCR 2025）

46.9分

★★★☆☆

站内排序·非疗效

Engineering adoptive cell therapy for solid tumors.

PubMed 2025/09/28 发表Med OncolQ2 · IF 4.7（JCR 2025）

40.6分

★★☆☆☆

站内排序·非疗效

前沿论文 4